Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Lytix Biopharma AS
Woman and Man Max 99 years
Lytix Biopharma AS
Update Il y a 4 ans
A randomised, double-blind, placebo-controlled, ascending dose Phase I/IIa study to evaluate the safety, tolerability and efficacy of topical LTX-109 in subjects nasally colonized with methicillin-resistant/-sensitive Staphylococcus aureus (MRSA/MSSA)
To determine: • Safety and tolerability of LTX-109 when applied topically to the anterior nares three times daily for three days. • Decolonization, eradication or no eradication of nasal MRSA/MSSA af...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Lytix Biopharma AS
Update Il y a 4 ans
A randomised, double-blind, placebo-controlled, Phase IIa pilot study to evaluate the safety, tolerability and efficacy of Lytixar™ (LTX-109) in patients with uncomplicated, Gram-positive, skin infection
• To determine the safety and local tolerability of topically administered Lytixar™ in patients with uncomplicated, Gram-positive, skin infection
Country
None
organs
None
Specialty
None
Closed trial
More information